Folate pathway enzymes and cofactors

The folate pathway enzymes and cofactors constitute a fundamental metabolic system responsible for one-carbon metabolism, which is essential for the de novo synthesis of purines and thymidylate required for DNA replication and repair [PubMed, NIH]. Key enzymes within this pathway, such as dihydrofolate reductase (DHFR) and thymidylate synthase (TS), serve as major therapeutic targets in oncology, where antifolate drugs like methotrexate and pemetrexed are employed to inhibit the proliferation of malignant cells [PMC, PubMed]. In the context of infectious diseases, the pathway is targeted by antimicrobial agents like sulfonamides and trimethoprim, which exploit the differences between microbial and human folate biosynthesis [PubMed, ResearchGate]. Beyond nucleotide synthesis, the pathway is critical for amino acid metabolism and the generation of S-adenosylmethionine (SAM), the primary methyl donor for DNA, RNA, and protein methylation [Wikipedia, NIH]. Dysregulation of folate metabolism is linked to several clinical conditions, including megaloblastic anemia, neural tube defects, and cardiovascular disease associated with hyperhomocysteinemia [NIH, PMC]. Monitoring folate status through biomarkers like serum and red blood cell folate, as well as genetic screening for MTHFR polymorphisms, is vital for optimizing therapeutic outcomes and managing drug-induced toxicities such as myelosuppression and mucositis [PubMed, StatPearls].

Other names

Folate metabolismOne-carbon metabolismFolate cycleTetrahydrofolate biosynthesisFolate-mediated one-carbon metabolism

Drugs targeting this pathway primarily act through the competitive inhibition of key enzymes such as dihydrofolate reductase (DHFR) and thymidylate synthase (TS), or by competing with para-aminobenzoic acid (PABA) in microbial folate synthesis (e.g., sulfonamides). These actions lead to the depletion of intracellular reduced folate pools, thereby disrupting the de novo synthesis of purine and pyrimidine nucleotides, which ultimately inhibits DNA and RNA synthesis and cell division [PubMed, NIH, PMC].